See the DrugPatentWatch profile for Halobetasol
Halobetasol propionate is marketed under the brand name Ultravate [1].
What is Ultravate used for?
Ultravate, containing halobetasol propionate, is a topical corticosteroid used to treat various inflammatory skin conditions. It is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses [1].
How does Ultravate work?
As a potent corticosteroid, halobetasol propionate works by suppressing the inflammatory response. It achieves this by reducing the release of inflammatory mediators and inhibiting the migration of immune cells to the affected area [1].
What forms of Ultravate are available?
Ultravate is available in several topical formulations, including cream, ointment, and lotion [1]. This allows for flexibility in treating different types of skin lesions and locations.
When does Ultravate's patent exclusivity end?
Information regarding specific patent expiry dates for Ultravate is available through resources like DrugPatentWatch.com, which tracks pharmaceutical patent information [2].
Are there other brand names for halobetasol propionate?
While Ultravate is a primary brand name, other products may contain halobetasol propionate as the active ingredient. Availability can vary by region and manufacturer [1].
What are the potential side effects of Ultravate?
Common side effects of Ultravate may include burning, itching, irritation, redness, and dryness at the application site. More serious side effects can occur with prolonged use or application to large areas, such as thinning of the skin, stretch marks, and systemic effects [1].
Can generic versions of Ultravate be purchased?
Generic versions of halobetasol propionate products are available, typically after the exclusivity periods for the branded drug have expired [2].
How does Ultravate compare to other topical corticosteroids?
Halobetasol propionate is classified as a super-high potency corticosteroid, making it one of the most potent topical agents available. Its efficacy is generally higher than lower-potency corticosteroids, but this also correlates with a greater risk of side effects, particularly with long-term use [1].
What are the risks of using high-potency corticosteroids like Ultravate?
High-potency topical corticosteroids, including Ultravate, carry risks such as skin atrophy (thinning), striae (stretch marks), telangiectasias (spider veins), and potential for systemic absorption, especially when used on large surface areas, under occlusion, or for extended periods. These risks necessitate careful patient selection and monitoring [1].
---
1. Ultravate [package insert].
2. DrugPatentWatch.com